TrialThe Journal of clinical endocrinology and metabolism2021

Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women.

Steve Pawsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.